These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18000915)

  • 1. Synthesis, modeling, and biological evaluation of analogues of the semisynthetic brevetoxin antagonist beta-naphthoyl-brevetoxin.
    Michelliza S; Abraham WM; Jacocks HM; Schuster T; Baden DG
    Chembiochem; 2007 Dec; 8(18):2233-9. PubMed ID: 18000915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway responses to aerosolized brevetoxins in an animal model of asthma.
    Abraham WM; Bourdelais AJ; Sabater JR; Ahmed A; Lee TA; Serebriakov I; Baden DG
    Am J Respir Crit Care Med; 2005 Jan; 171(1):26-34. PubMed ID: 15447946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brevetoxins bind to multiple classes of sites in rat brain synaptosomes.
    Edwards RA; Trainer VL; Baden DG
    Brain Res Mol Brain Res; 1992 Jun; 14(1-2):64-70. PubMed ID: 1323018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and utilization of a fluorescence-based receptor-binding assay for the site 5 voltage-sensitive sodium channel ligands brevetoxin and ciguatoxin.
    McCall JR; Jacocks HM; Niven SC; Poli MA; Baden DG; Bourdelais AJ
    J AOAC Int; 2014; 97(2):307-15. PubMed ID: 24830141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new polyether ladder compound produced by the dinoflagellate Karenia brevis.
    Bourdelais AJ; Jacocks HM; Wright JL; Bigwarfe PM; Baden DG
    J Nat Prod; 2005 Jan; 68(1):2-6. PubMed ID: 15679307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of tamulamides A and B, polyethers isolated from the marine dinoflagellate Karenia brevis.
    Truxal LT; Bourdelais AJ; Jacocks H; Abraham WM; Baden DG
    J Nat Prod; 2010 Apr; 73(4):536-40. PubMed ID: 20218657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brevetoxin binding: molecular pharmacology versus immunoassay.
    Baden DG; Mende TJ; Szmant AM; Trainer VL; Edwards RA; Roszell LE
    Toxicon; 1988; 26(1):97-103. PubMed ID: 3347935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic potency of synthetically prepared brevetoxin cysteine metabolites BTX-B2 and desoxyBTX-B2.
    Dechraoui MY; Wang Z; Ramsdell JS
    Toxicon; 2007 Nov; 50(6):825-34. PubMed ID: 17689582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brevetoxin derivatives act as partial agonists at neurotoxin site 5 on the voltage-gated Na+ channel.
    LePage KT; Baden DG; Murray TF
    Brain Res; 2003 Jan; 959(1):120-7. PubMed ID: 12480165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brevenal, a brevetoxin antagonist from Karenia brevis, binds to a previously unreported site on mammalian sodium channels.
    Gold EP; Jacocks HM; Bourdelais AJ; Baden DG
    Harmful Algae; 2013 Jun; 26():12-19. PubMed ID: 23789024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes.
    Trainer VL; Thomsen WJ; Catterall WA; Baden DG
    Mol Pharmacol; 1991 Dec; 40(6):988-94. PubMed ID: 1661842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brevenal is a natural inhibitor of brevetoxin action in sodium channel receptor binding assays.
    Bourdelais AJ; Campbell S; Jacocks H; Naar J; Wright JL; Carsi J; Baden DG
    Cell Mol Neurobiol; 2004 Aug; 24(4):553-63. PubMed ID: 15233378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxic shellfish poisoning.
    Watkins SM; Reich A; Fleming LE; Hammond R
    Mar Drugs; 2008; 6(3):431-55. PubMed ID: 19005578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex behavior of marine animal tissue extracts in the competitive binding assay of brevetoxins with rat brain synaptosomes.
    Whitney PL; Delgado JA; Baden DG
    Nat Toxins; 1997; 5(5):193-200. PubMed ID: 9496378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Determinants of Brevetoxin Binding to Voltage-Gated Sodium Channels.
    Konoki K; Baden DG; Scheuer T; Catterall WA
    Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31484365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure activity relationship of brevenal hydrazide derivatives.
    Goodman A; McCall JR; Jacocks HM; Thompson A; Baden D; Abraham WM; Bourdelais A
    Mar Drugs; 2014 Mar; 12(4):1839-58. PubMed ID: 24686558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalation toxicity of brevetoxin 3 in rats exposed for 5 days.
    Benson J; Hahn F; March T; McDonald J; Sopori M; Seagrave J; Gomez A; Bourdelais A; Naar J; Zaias J; Bossart G; Baden D
    J Toxicol Environ Health A; 2004 Sep; 67(18):1443-56. PubMed ID: 15371231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semisynthesis of S-desoxybrevetoxin-B2 and brevetoxin-B2, and assessment of their acute toxicities.
    Selwood AI; Ginkel Rv; Wilkins AL; Munday R; Ramsdell JS; Jensen DJ; Cooney JM; Miles CO
    Chem Res Toxicol; 2008 Apr; 21(4):944-50. PubMed ID: 18335998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of brevetoxin binding to the voltage-gated sodium channel by gambierol and gambieric acid-A.
    Inoue M; Hirama M; Satake M; Sugiyama K; Yasumoto T
    Toxicon; 2003 Mar; 41(4):469-74. PubMed ID: 12657316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemodiversity of Brevetoxins and Other Potentially Toxic Metabolites Produced by
    Hort V; Abadie E; Arnich N; Dechraoui Bottein MY; Amzil Z
    Mar Drugs; 2021 Nov; 19(12):. PubMed ID: 34940655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.